Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI)- Gamma Communications Plc
-
Allot to Present at the 21st Annual Needham Technology, Media & Consumer Conference on May 13, 2026
-
Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
-
Form 8.5 (EPT/RI)-NCC Group plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - NCC GROUP PLC - Ordinary Shares
-
Canadians would rather do just about anything than read their home insurance policy, Allstate Canada survey finds
-
Allot to Present at the 21st Annual Needham Technology, Media & Consumer Conference on May 13, 2026
-
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
-
Darren Gilmour to Step Down as Executive Director of the Royal Society of Canada (RSC)
-
Tri Pointe Homes, Inc. Reports 2026 First Quarter Results
-
Constellium Reports Strong First Quarter 2026 Results, including Record Quarterly Segment Adjusted EBITDA; Raises Full Year 2026 Guidance
-
First Atlantic Nickel & Cobalt Welcomes Dr. Douglas Wicks, Former Program Director for the U.S. Department of Energy's ARPA-E (Advanced Research Projects Agency-Energy) Miner Program and Geol
-
Auddia Highlights $12M Financing as Catalyst to Unlock Distributed AI Datacenter Value Through Merger Acceleration
-
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs
-
Generac Reports First Quarter 2026 Results
-
Goranson Bain Ausley Welcomes Family Lawyer Alina Caratas to Dallas Office
-
LXP Industrial Trust Reports First Quarter 2026 Results
-
Behind the numbers: Billing concerns continue to drive rising telecom and TV complaints
-
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
-
KBR’s Mission Technology Solutions Wins $510 Million Contract to Provide Joint Data and Analytic Support Services to the Department of War
-
Atour Lifestyle Holdings Limited to Report First Quarter 2026 Financial Results on May 13, 2026
-
Montage Gold completes the acquisition of African Gold
-
Gogoro Announces Results of Annual General Meeting of Shareholders
-
MEXC and Sumsub Partner to Strengthen Global Compliance and Combat Emerging Identity Fraud Risks
-
Ridgeline Introduces AI-Powered, Real-time Market News in its Investment Management Platform
-
Aviatrix Operationalizes the Containment Era with the Industry's First Containment Platform for AI Agents
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Utenos trikotažas RAB annual information 2025
-
Lithia & Driveway (LAD) Reports First Quarter Results
-
Decisions of the General Meeting of Shareholders in 2026 april 29
-
Form 8.3 - [ANIMALCARE GROUP PLC - 28 04 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 28 04 2026] - (CGWL)
-
Kyivstar and VEON Fulfill Commitment to Invest $1 Billion Investment Program in Ukraine, Exceeding Target by 30%
-
VEON and Kyivstar Fulfill Commitment to Invest USD 1 Billion in Ukraine over 2023-2027 Ahead of Schedule
-
Han’s Laser Exhibits Advanced Technological Prowess at Hannover Messe 2026
-
Sale of Ontario gold assets completes
-
IUX Releases New Analysis on Fed Leadership and Dollar Strength Impacting Global Markets
-
KAYAK Launches Ask AI to Simplify Travel Planning
-
Reduction of share capital by cancellation of own shares
-
Transaction in Own Shares
-
Toobit Introduces Futures Position Vouchers, Combining Exchange-Backed Margin with 100% Profit Gains
-
STARTRADER Transforms Basketball Court for 10,000 Youth Annually in Vietnam
-
Trident Intersects 15.11 g/t Au over 51.83m from 256.0m in the BK3 Zone at the Contact Lake Gold Project, Saskatchewan
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Sampo Group's results for January-March 2026 will be published on 6 May 2026
-
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
-
Combined General Shareholders' Meeting of May 20, 2026: availability of preliminary documents

